Global Radiopharmaceuticals Bone Disease Market 2017-2023 by Type, Procedural Volume, Application, End User & Region - ResearchAndMarkets.com

September 12, 2018

DUBLIN--(BUSINESS WIRE)--Sep 12, 2018--The “Global Radiopharmaceuticals Bone Disease Market - by Type, Procedural Volume, Application, End User, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)” report has been added to ResearchAndMarkets.com’s offering.

The Global Radiopharmaceuticals Bone Disease Market was worth 5.2 Billion USD in 2017 and it is estimated to grow to 7.12 Billion USD by 2023 with a CAGR of 5.38% between 2017 and 2023.Some unique medicinal formulations which mainly contain radioisotopes are generally known as radiopharmaceuticals. These radiopharmaceuticals are used for diagnostic and therapeutic purposes. Radiopharmaceuticals are majorly divided into four categories namely radiopharmaceutical preparation, radionuclide generator, radiopharmaceutical precursor and radiopharmaceutical preparation kit.

North America holds the largest share of Global Radiopharmaceuticals Market followed by Europe & Asia-Pacific.

Drivers Vs. Constraints

The growing incidence of cancer and cardiovascular diseases, rise in aging population, unhealthy food habits, prevalence of obesity are the factors driving the Global Radiopharmaceuticals Market.

Industry Structure and Updates

In 2014, AAA a key company acquired GE Healthcare S.r.L’s FDG-PET business as well as the complete shares of Imaging Equipment Ltd (IEL).

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Radiopharmaceuticals Market Segmentation, Forecasts and Trends - by Type

5.1. Diagnostics

5.1.1. SPECT Radiopharmaceuticals Technetium-99m Thallium-201 Gallium-67 Iodine-123 Others

5.1.2. PET Radiopharmaceuticals Fluorine-18 Rubidium-82 Others

5.2. Therapeutics

5.2.1. Beta Emitters Iodine-131 Samarium-153 Rhenium-186 Yttrium-90 Lutetium-177 Others

5.2.2. Alpha Emitters Iodine-131

5.2.3. Brachytherapy Isotopes Iodine-125 Palladium-103 Cesium-131 Iridium-192 Others

6. Global Radiopharmaceuticals Market Segmentation, Forecasts and Trends - by Procedural Volume

6.1. Diagnostics Market

6.1.1. SPECT

6.1.2. PET

6.2. Therapeutics Market

6.2.1. Beta Emitters

6.2.2. Alpha Emitters

6.2.3. Brachytherapy Isotopes

7. Global Radiopharmaceuticals Market Segmentation, Forecasts and Trends - by Application

7.1. Diagnostics

7.1.1. SPECT Cardiology Lymphoma Neurology Thyroid Others

7.1.2. PET Radiopharmaceuticals Oncology Cardiology Neurology Others

7.2. Therapeutics

7.2.1. Thyroid

7.2.2. Bone Metastasis

7.2.3. Lymphoma

7.2.4. Endocrine Tumors

7.2.5. Others

8. Global Radiopharmaceuticals Market Segmentation, Forecasts and Trends - by End User

8.1. Hospitals

8.2. Ambulatory Surgical Centers

8.3. Diagnostic Centers

8.4. Others

9. Global Radiopharmaceuticals Market Segmentation, Forecasts and Trends - by Region

10. Company Market Share Analysis

11. Company Profiles

12. Industry Structure

12.1. Industry M&As, Consolidations

12.2. Investment Opportunities

13. Global Radiopharmaceuticals Market - Road Ahead

Companies Mentioned

Cardinal HealthGE HealthcareCuriumBayerLantheus Medical ImagingAdvanced Accelerator ApplicationsJubilant Life SciencesMedtronic, Inc.IBA GroupMallinckrodt plc.General Electric Co.For more information about this report visit https://www.researchandmarkets.com/research/j2znl8/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180912005493/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Nuclear Medicine and Radiopharmacology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/12/2018 06:15 AM/DISC: 09/12/2018 06:15 AM


Update hourly